UPDATE FOR AUTHOR SUBMISSIONS Authors must now submit using the JFDA editorialmanager.com site at the following URL: https://www.editorialmanager.com/JFDA/default.aspx JFDA will require authors to re-submit via the JFDA editorialmanager.com site for any submissions made on the JFDA Digital Commons site.
Authorship & Conflicts of Interest Statement
JFDA Copyright Transfer Agreement
Instructions for Authors
The Editorial and Peer Review Process
As a general rule, the receipt of a manuscript will be acknowledged within 2 weeks of submission, and authors will be provided with a manuscript reference number for future correspondence. If such an acknowledgment is not received in a reasonable period of time, the author should contact the Editorial Office. Submissions are reviewed by the Editorial Office to ensure that it contains all parts. Submissions will be rejected if the author has not supplied all the material and documents as outlined in these author instructions. Manuscripts are then forwarded to the Editor-in-Chief, who makes an initial assessment of it. If the manuscript does not appear to be of sufficient merit or is not appropriate for the Journal, then the manuscript will be rejected without review. Rejected manuscripts will not be returned to authors unless requested.
Manuscripts that appear meritorious and appropriate for the Journal are reviewed by at least two Editorial Board members or expert consultants assigned by the Editor-in-Chief. Authors may submit a list in their cover letter of reviewers who they wish to review or not to review their manuscript. However, the actual peer reviewers invited will remain anonymous and may or may not be the reviewers suggested by the authors as the selection of reviewers is at the sole discretion of JFDA Editors. The editors and reviewers will not disclose any information about a manuscript or its review to anyone except the manuscript’s corresponding author. The corresponding author will usually be notified within 10 weeks of whether the submitted article is accepted for publication, rejected, or subject to revision before acceptance (however, do note that delays are sometimes unavoidable). If revisions are required, authors are asked to return a revised manuscript to the Editorial Office via the EM platform within 30 days. Please notify the Editorial Office in advance if additional time is needed or if you choose not to submit a revised manuscript.
The JFDA is the official peer-reviewed publication of TFDA. Manuscripts published in the JFDA become the permanent property of TFDA. All articles published in the Journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article, as well as translation rights. No JFDA article, in part or whole, may be reproduced, stored in any retrieval system, or transmitted in any form or by any means, electronic, mechanical, by photocopying, recording, or otherwise, without prior written permission from TFDA.
Permission to Reuse
No part of materials published in Journal of Food and Drug Analysis may be reproduced without written permission of the publisher.
Questions about obtaining permission? Contact the .
For information on requesting permission to reuse published Journal of Food and Drug Analysis materials, contact the .
Please contact the for permission forms and for more information about how to obtain permission to reproduce published data.
Some requests from other STM signatory publishers qualify for gratis reuse. See the STM website for details: http://www.stm-assoc.org/permissions-guidelines/.